UCB - Cash And Equivalent

Stock Price
266.50
Daily Change
5.50 2.11%
Monthly
13.45%
Yearly
42.59%
Q1 Forecast
249.19

UCB reported EUR1.57B in Cash and Equivalent for its fiscal semester ending in December of 2024.





Cash And Equivalent Change Date
Alcon AG USD 1.5B 90M Sep/2025
Amarin USD 122.8M 25.08M Sep/2025
argenx SE USD 4.3B 2.21B Sep/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
Bayer EUR 5.9B 1.34B Sep/2025
Galapagos EUR 64.46M 43.61M Sep/2025
Genmab DKK 1.3B 323M Jun/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Lonza CHF 1.11B 286M Dec/2024
Merck EUR 1.17B 161M Jun/2025
Novartis USD 9.56B 2.9B Sep/2025
Orion EUR 224.2M 35.2M Sep/2025
Recordati EUR 341.55M 8.51M Jun/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
UCB EUR 1.57B 1.14B Dec/2024
Unibail Rodamco EUR 5.29B 668.7M Dec/2024